Volume 1, Issue 2 (2022)                   GMJM 2022, 1(2): 47-50 | Back to browse issues page
Article Type:
Descriptive & Survey |
Subject:

Print XML PDF HTML


History

How to cite this article
Yasrebinia S. Role of Vitamins and Minerals in Short Stature of Children. GMJM 2022; 1 (2) :47-50
URL: http://gmedicine.de/article-2-192-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rights and permissions
Authors S. Yasrebinia *
University of Medical Sciences, Tabriz, Iran
* Corresponding Author Address: Tabriz University of Medical Sciences, Tabriz, Iran (sanaz.1359@yahoo.com)
Abstract   (528 Views)
Aims: Short stature in children can occur in two stages before birth (embryonic stage) and after birth or in both stages. During pregnancy, the mother plays an important role in this regard.
Instrument & Methods: This descriptive-analytic study was conducted during 2018 with participation of 122 children with type 2 diabetes. Sampling by non-probable and ready-made method was conducted by examining the records of patients with diabetes referring to the office of the physicians of the children of Tabriz University of Medical Sciences. Data were analyzed in SPSS 21 software. Pearson correlation test was used to analyze the data.
Findings: The mean serum calcium level was 9.45±0.85mg/dl and the average serum levels of vitamin D were 10.99±1.14ng/ml. Serum vitamin D levels were divided into three levels of severe deficiency, mild and natural deficiency. Body mass index and diabetes time based on vitamin D and calcium group showed a significant difference between groups.
Conclusion: The role of several micronutrients in ensuring adequate growth in children is well known. But it is not yet clear which of them has the greatest impact on children's developmental delay.
 
Keywords:
|   |   Full-Text (HTML)  (74 Views)  

References
1. Gupta G, de Jesus Andreoli Pinto T, Chellappan DK, Mishra A, Malipeddi H, Dua K. A clinical update on metformin and lung cancer in diabetic patients. Panminerva Med. 2018;60(2):70-5. [Link] [DOI:10.23736/S0031-0808.18.03394-3]
2. Xin GLL, Khee YP, Ying TY, Chellian J, Gupta G, Kunnath AP, et al. Current status on immunological therapies for type 1 Diabetes mellitus. Curr Diab Rep. 2019;19(5);22. [Link] [DOI:10.1007/s11892-019-1144-3]
3. Miettinen ME, Smart MC, Kinnunen L, Harjutsalo V, Reinert-Hartwall L, Ylivinkka I, et al. Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child. PloS One. 2017;12:e0184942. [Link] [DOI:10.1371/journal.pone.0184942]
4. Penna-Martinez M, Badenhoop K. Inherited variation in Vitamin D Genes and Type 1 Diabetes predisposition. Genes. 2017;8(4):125. [Link] [DOI:10.3390/genes8040125]
5. Nam HK, Rhie YJ, Lee YH. Vitamin D level and gene polymorphisms in Korean children with type 1 diabetes. Pediatric Diabetes. 2019;20(6):750-8. [Link] [DOI:10.1111/pedi.12878]
6. Ahmed AE, Sakhr HM, Hassan MH, El-Amir MI, Ameen HH. Vitamin D receptor rs7975232, rs731236 and rs1544410 single nucleotide polymorphisms, and 25-hydroxyvitamin D levels in Egyptian children with type 1 diabetes mellitus: effect of vitamin D co-therapy. Diabetes Metab Syndr Obes. 2019;12:703-16. [Link] [DOI:10.2147/DMSO.S201525]
7. Habibian N, Amoli MM, Abbasi F, Rabbani A, Alipour A, Sayarifard F, et al. Role of vitamin D and vitamin D receptor gene polymorphisms on residual beta cell function in children with type 1 diabetes mellitus. Pharmacol Rep. 2019;71(2):282-8. [Link] [DOI:10.1016/j.pharep.2018.12.012]
8. Rasoul MA, Haider MZ, Al-Mahdi M, Al-Kandari H, Dhaunsi GS. Relationship of four vitamin D receptor gene polymorphisms with type 1 diabetes mellitus susceptibility in Kuwaiti children. BMC Pediatrics. 2019;19(1):71. [Link] [DOI:10.1186/s12887-019-1448-0]
9. Ali R, Fawzy I, Mohsen I, Settin A. Evaluation of vitamin D receptor gene polymorphisms (Fok-I and Bsm-I) in T1DM Saudi children. J Clin Lab Anal. 2018;32(5):e22397. [Link] [DOI:10.1002/jcla.22397]
10. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;349:g7647. [Link] [DOI:10.1136/bmj.g7647]
11. Zhang Q, Jin Y, Li X, Peng X, Peng N, Song J, et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism- a meta-analysis and systematic review. VASA. 2020;49(2):141-6. [Link] [DOI:10.1024/0301-1526/a000839]
12. Zhang W, Xu Y. Association between Vitamin D receptor gene polymorphism rs2228570 and allergic rhinitis. Pharmgenomics Pers Med. 2020;13:327-35. [Link] [DOI:10.2147/PGPM.S262402]
13. Al-Eisa AA, Haider MZ. Vitamin D receptor gene TaqI and Apal polymorphisms and steroid responsiveness in childhood idiopathic nephrotic syndrome. Int J Nephrol Renovasc Dis. 2016;9:187-92. [Link] [DOI:10.2147/IJNRD.S111538]
14. Rejnmark L, Bislev LS, Cashman KD, Eiríksdottir G, Gaksch M, Grübler M, et al. Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS One. 2017;12(7):e0180512. [Link] [DOI:10.1371/journal.pone.0180512]
15. Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. Vitamin D deficiency in Europe: Pandemic?. Am J Clin Nutr. 2016;103(4):1033-44. [Link] [DOI:10.3945/ajcn.115.120873]
16. Sethuraman U, Zidan MA, Hanks L, Bagheri M, Ashraf A. Impact of vitamin D treatment on 25 hydroxy vitamin D levels and insulin homeostasis in obese African American adolescents in a randomized trial. J Clin Transl Endocrinol. 2018;12:13-9. [Link] [DOI:10.1016/j.jcte.2018.03.002]
17. Magge SN, Prasad D, Zemel BS, Kelly A. Vitamin D3 supplementation in obese, African-American, vitamin D deficient adolescents. J Clin Transl Endocrinol. 2018;12:1-7. [Link] [DOI:10.1016/j.jcte.2018.03.001]
18. Brar PC, Contreras M, Fan X, Visavachaipan N. Effect of one time high dose "stoss therapy" of vitamin D on glucose homeostasis in high risk obese adolescents. Arch Endocrinol Metab. 2018;62(2):193-200. [Link] [DOI:10.20945/2359-3997000000024]
19. Smith TJ, Tripkovic L, Hauger H, Damsgaard CT, Mølgaard C, Lanham-New SA, et al. Winter cholecalciferol supplementation at 51°N has no effect on markers of cardiometabolic risk in healthy adolescents aged 14-18 years. J Nutr. 2018;148(8):1269-75. [Link] [DOI:10.1093/jn/nxy079]
20. Hauger H, Mølgaard C, Mortensen C, Ritz C, Frøkiær H, Smith TJ, et al. Winter cholecalciferol supplementation at 55°n has no effect on markers of cardiometabolic risk in healthy children aged 4-8 years. J Nutr. 2018;148(8):1261-8. [Link] [DOI:10.1093/jn/nxy080]
21. Ferira AJ, Laing EM, Hausman DB, Hall DB, McCabe GP, Martin BR, et al. Vitamin D supplementation does not impact insulin resistance in black and white children. J Clin Endocrinol Metab. 2016;101(4):1710-8. [Link] [DOI:10.1210/jc.2015-3687]